- Home
- PHAR vs TGB Comparison
PHAR vs TGB Comparison
Compare PHAR & TGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHAR | TGB |
|---|---|---|
| Founded | 1988 | 1966 |
| Country | Netherlands | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 2.1B |
| IPO Year | 2020 | 2002 |
Fundamental Metrics
Financial Performance| Metric | PHAR | TGB |
|---|---|---|
| Price | $16.37 | $6.71 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 1 |
| Target Price | ★ $39.00 | $5.00 |
| AVG Volume (30 Days) | 18.0K | ★ 4.8M |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.04 | $67.93 |
| Revenue Next Year | $2.51 | $24.16 |
| P/E Ratio | $3,041.22 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.79 | $1.83 |
| 52 Week High | $21.34 | $9.25 |
Technical Indicators
Market Signals| Indicator | PHAR | TGB |
|---|---|---|
| Relative Strength Index (RSI) | 55.12 | 50.43 |
| Support Level | $16.55 | $5.36 |
| Resistance Level | $17.60 | $9.08 |
| Average True Range (ATR) | 0.61 | 0.36 |
| MACD | 0.15 | 0.12 |
| Stochastic Oscillator | 81.86 | 89.16 |
Price Performance
Historical ComparisonAbout PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About TGB Taseko Mines Ltd.
Taseko Mines Ltd is a copper-focused mining company engaged in acquiring, developing, and operating large tonnage mineral deposits in stable jurisdictions that are capable of supporting a mine. Its principal assets are the wholly-owned Gibraltar mine (Gibraltar), which is located in central British Columbia (BC), and the Florence Copper mine, located in Arizona. Taseko also owns the Yellowhead copper, New Prosperity copper-gold, and Aley niobium projects in British Columbia, Canada.